Literature DB >> 29230285

Cellular senescence associated immune responses in liver cancer.

Tim F Greten1,1, Tobias Eggert2,2.   

Abstract

Cellular senescence is a stress-induced cell-cycle arrest program that prevents malignant transformation of senescent cells following oncogenic pathway activation and DNA damage. Senescent cells are metabolically active and secrete cytokines and chemokines that shape the function and composition of their microenvironment. These cytokines can recruit immune cells such as lymphocytes and myeloid cells that depending on the context can either promote or inhibit liver tumor development and progression. Accordingly, pharmacologically targeting of secreted cytokines or reprogramming the expression of these cytokines in senescent cells represents a promising approach to skew senescence-associated immune responses toward cancer cell killing.

Entities:  

Keywords:  SASP; hepatocellular carcinoma; immune cells; liver; senescence; tumor

Year:  2017        PMID: 29230285      PMCID: PMC5716390          DOI: 10.2217/hep-2017-0011

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  27 in total

1.  Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation.

Authors:  Joo Song Lim; Sun-Hye Park; Kyung Lib Jang
Journal:  Cancer Lett       Date:  2012-02-07       Impact factor: 8.679

2.  Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.

Authors:  Alberto Toso; Ajinkya Revandkar; Diletta Di Mitri; Ilaria Guccini; Michele Proietti; Manuela Sarti; Sandra Pinton; Jiangwen Zhang; Madhuri Kalathur; Gianluca Civenni; David Jarrossay; Erica Montani; Camilla Marini; Ramon Garcia-Escudero; Eugenio Scanziani; Fabio Grassi; Pier Paolo Pandolfi; Carlo V Catapano; Andrea Alimonti
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

3.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Authors:  Shin Yoshimoto; Tze Mun Loo; Koji Atarashi; Hiroaki Kanda; Seidai Sato; Seiichi Oyadomari; Yoichiro Iwakura; Kenshiro Oshima; Hidetoshi Morita; Masahira Hattori; Masahisa Hattori; Kenya Honda; Yuichi Ishikawa; Eiji Hara; Naoko Ohtani
Journal:  Nature       Date:  2013-06-26       Impact factor: 49.962

Review 4.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

5.  Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.

Authors:  Jiejie Xu; Xiaojing Yun; Jianhai Jiang; Yuanyan Wei; Yihong Wu; Wei Zhang; Yeheng Liu; Wenzhong Wang; Yumei Wen; Jianxin Gu
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

6.  Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.

Authors:  Tobias Eggert; Katharina Wolter; Juling Ji; Chi Ma; Tetyana Yevsa; Sabrina Klotz; José Medina-Echeverz; Thomas Longerich; Marshonna Forgues; Florian Reisinger; Mathias Heikenwalder; Xin Wei Wang; Lars Zender; Tim F Greten
Journal:  Cancer Cell       Date:  2016-10-10       Impact factor: 31.743

Review 7.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.

Authors:  Jean-Philippe Coppé; Christopher K Patil; Francis Rodier; Yu Sun; Denise P Muñoz; Joshua Goldstein; Peter S Nelson; Pierre-Yves Desprez; Judith Campisi
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

10.  A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Authors:  Juan Carlos Acosta; Ana Banito; Torsten Wuestefeld; Athena Georgilis; Peggy Janich; Jennifer P Morton; Dimitris Athineos; Tae-Won Kang; Felix Lasitschka; Mindaugas Andrulis; Gloria Pascual; Kelly J Morris; Sadaf Khan; Hong Jin; Gopuraja Dharmalingam; Ambrosius P Snijders; Thomas Carroll; David Capper; Catrin Pritchard; Gareth J Inman; Thomas Longerich; Owen J Sansom; Salvador Aznar Benitah; Lars Zender; Jesús Gil
Journal:  Nat Cell Biol       Date:  2013-06-16       Impact factor: 28.824

View more
  6 in total

Review 1.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

Review 2.  Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.

Authors:  Ibrahim Y Abdelgawad; Kevin Agostinucci; Beshay N Zordoky
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-01-15       Impact factor: 5.187

3.  Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce.

Authors:  Qian Li; Carolina E Hagberg; Helena Silva Cascales; Shuai Lang; Mervi T Hyvönen; Firoozeh Salehzadeh; Ping Chen; Ida Alexandersson; Eleni Terezaki; Matthew J Harms; Maria Kutschke; Nahida Arifen; Niels Krämer; Myriam Aouadi; Carole Knibbe; Jeremie Boucher; Anders Thorell; Kirsty L Spalding
Journal:  Nat Med       Date:  2021-10-04       Impact factor: 53.440

Review 4.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

5.  Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.

Authors:  Denian Wang; Fei Xiao; Zhongxue Feng; Min Li; Lingmiao Kong; Luping Huang; Yong'gang Wei; Hongyu Li; Fei Liu; Haili Zhang; Wei Zhang
Journal:  Breast Cancer Res       Date:  2020-09-29       Impact factor: 6.466

6.  The Cancer SENESCopedia: A delineation of cancer cell senescence.

Authors:  Fleur Jochems; Bram Thijssen; Giulia De Conti; Robin Jansen; Ziva Pogacar; Kelvin Groot; Liqin Wang; Arnout Schepers; Cun Wang; Haojie Jin; Roderick L Beijersbergen; Rodrigo Leite de Oliveira; Lodewyk F A Wessels; René Bernards
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.